संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - methadone hydrochloride (unii: 229809935b) (methadone - unii:uc6vbe7v1z) - methadone hydrochloride tablets are indicated for the: limitations of use methadone products used for the treatment of opioid addiction in detoxification or maintenance programs are subject to the conditions for distribution and use required under 42 cfr 8.12 [see dosage and administration (2.1)] . methadone hydrochloride tablets are contraindicated in patients with: risk summary neonatal opioid withdrawal syndrome (nows) is an expected and treatable outcome of prolonged use of opioids during pregnancy [see warnings and precautions (5.4)]. pregnant women in methadone maintenance programs may have reduced incidence of obstetric and fetal complications and neonatal morbidity and mortality when compared to women using illicit drugs. untreated opioid addiction in pregnancy is associated with adverse obstetrical outcomes and risk of continued or relapsing illicit opioid use. these risks should be considered in women treated with methadone hydrochloride tablets for maintenance treatment of opioid addiction. for wom

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

atlantic biologicals corp. - methadone hydrochloride (unii: 229809935b) (methadone - unii:uc6vbe7v1z) - methadone hydrochloride intensoltm (oral concentrate) is indicated for the: conditions for distribution and use of methadone products for the treatment of opioid addiction code of federal regulations, title 42, sec 8 methadone products when used for the treatment of opioid addiction in detoxification or maintenance programs, shall be dispensed only by opioid treatment programs (and agencies, practitioners or institutions by formal agreement with the program sponsor) certified by the substance abuse and mental health services administration and approved by the designated state authority. certified treatment programs shall dispense and use methadone in oral form only and according to the treatment requirements stipulated in the federal opioid treatment standards (42 cfr 8.12). see below for important regulatory exceptions to the general requirement for certification to provide opioid agonist treatment. failure to abide by the requirements in these regulations may result in criminal prosecution, seizure of the

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

mallinckrodt, inc. - methadone hydrochloride (unii: 229809935b) (methadone - unii:uc6vbe7v1z) - methadone hydrochloride 1 g in 1 g - 1.  for detoxification treatment of opioid addiction (heroin or other morphine-like drugs). 2.  for maintenance treatment of opioid addiction (heroin or other morphine-like drugs), in conjunction with appropriate social and medical services. conditions for distribution and use of methadone products for the treatment of opioid addiction code of federal regulations, title 42, sec 8. methadone products when used for the treatment of opioid addiction in detoxification or maintenance programs, shall be dispensed only by opioid treatment programs (and agencies, practitioners or institutions by formal agreement with the program sponsor) certified by the substance abuse and mental health services administration and approved by the designated state authority. certified treatment programs shall dispense and use methadone in oral form only and according to the treatment requirements stipulated in the federal opioid treatment standards (42 cfr 8.12). see below for important regulatory exceptions to the general requiremen

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

cebert pharmaceuticals, inc. - methadone hydrochloride (unii: 229809935b) (methadone - unii:uc6vbe7v1z) - concentrate - 10 mg in 1 ml - - detoxification treatment of opioid addiction (heroin or other morphine-like drugs). - maintenance treatment of opioid addiction (heroin or other morphine-like drugs), in conjunction with appropriate social and medical services. outpatient maintenance and outpatient detoxification treatment may be provided only by opioid treatment programs (otps) certified by the federal substance abuse and mental health services administration (samhsa) and registered by the drug enforcement administration (dea). this does not preclude the maintenance treatment of a patient with concurrent opioid addiction who is hospitalized for conditions other than opioid addiction and who requires temporary maintenance during the critical period of his/her stay, or of a patient whose enrollment has been verified in a program which has been certified for maintenance treatment with methadone. methadone hydrochloride oral concentrate is contraindicated in patients with a known hypersensitivity to methadone hydrochloride or any other ingred

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

physicians total care, inc. - methadone hydrochloride (unii: 229809935b) (methadone - unii:uc6vbe7v1z) - methadone 5 mg - - for the treatment of moderate to severe pain not responsive to non-narcotic analgesics. - for detoxification treatment of opioid addiction (heroin or other morphine-like drugs). - for maintenance treatment of opioid addiction (heroin or other morphine-like drugs), in conjunction with appropriate social and medical services. note – outpatient maintenance and outpatient detoxification treatment may be provided only by opioid treatment programs (otps) certified by the federal substance abuse and mental health services administration (samhsa) and registered by the drug enforcement administration (dea). this does not preclude the maintenance treatment of a patient with concurrent opioid addiction who is hospitalized for conditions other than opioid addiction and who requires temporary maintenance during the critical period of his/her stay, or of a patient whose enrollment has been verified in a program which has been certified for maintenance treatment with methadone. methadone is contraindicated in

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

xanodyne pharmaceuticals inc. - methadone hydrochloride (unii: 229809935b) (methadone - unii:uc6vbe7v1z) - injection, solution - 10 mg in 1 ml - - for the treatment of moderate to severe pain not responsive to non-narcotic analgesics. - for use in temporary treatment of opioid dependence in patients unable to take oral medication. outpatient maintenance and outpatient detoxification treatment may be provided only by opioid treatment programs (otps) certified by the federal substance abuse and mental health services administration (samhsa) and registered by the drug enforcement administration (dea). this does not preclude the maintenance treatment of a patient with concurrent opioid addiction who is hospitalized for conditions other than opioid addiction and who requires temporary maintenance during the critical period of hospitalization, or of a patient whose enrollment has been verified in a program which has been certified for maintenance treatment with methadone. note : injectable methadone products are not approved for the outpatient treatment of opioid dependence. in this patient population, parenteral methadone is to be used only for patients un

कनाडा - अंग्रेज़ी - Health Canada

sterinova inc. - methadone hydrochloride - solution - 10mg - methadone hydrochloride 10mg - opiate agonists

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

vistapharm, inc. - methadone hydrochloride (unii: 229809935b) (methadone - unii:uc6vbe7v1z) - methadone hydrochloride tablets are indicated for the: - management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. limitations of use because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with long-acting opioids [see warnings and precautions  (5.1) ], reserve methadone hydrochloride tablets for use in patients for whom alternative analgesic treatment options (e.g., non-opioid analgesics or immediate-release opioid analgesics) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. methadone hydrochloride tablets are not indicated as an as-needed (prn) analgesic. limitations of use - because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with long-acting opioids [see warn

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - methadone hydrochloride 1 mg/ml - oral solution - 1 mg/ml - active: methadone hydrochloride 1 mg/ml excipient: brilliant blue fcf cherry flavour it1037 citric acid monohydrate glycerol hyetellose purified water sodium benzoate tartrazine xylitol - indicated in detoxification and maintenance treatment as a substitute for heroin or other morphine-like drugs to suppress the opiate-agonist abstinence syndrome in patients who are dependent on these drugs.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - methadone hydrochloride 5 mg/ml - oral solution - 5 mg/ml - active: methadone hydrochloride 5 mg/ml excipient: caramel cherry flavour it1037 citric acid monohydrate glycerol hyetellose purified water sodium benzoate xylitol - indicated in detoxification and maintenance treatment as a substitute for heroin or other morphine-like drugs to suppress the opiate-agonist abstinence syndrome in patients who are dependent on these drugs.